Prevalence and Characteristics of Sleep Apnea in Intensive Care Unit Survivors After SARS-CoV-2 Pneumonia

被引:4
作者
Traore, Ibrahim [1 ]
Eberst, Guillaume [1 ,2 ,3 ]
Claude, Frederic [1 ]
Laurent, Lucie [1 ]
Meurisse, Aurelia [2 ,3 ]
Paget-Bailly, Sophie [2 ,3 ]
Roux-Claude, Pauline [1 ]
Jacoulet, Pascale [1 ]
Barnig, Cindy [1 ]
Martarello, Rachel [1 ]
Poirson, Bastien [4 ]
Bouiller, Kevin [5 ]
Chirouze, Catherine [5 ]
Behr, Julien [6 ]
Grillet, Franck [6 ]
Ritter, Ophelie [1 ]
Pili-Floury, Sebastien [7 ]
Winiszewski, Hadrien [8 ]
Samain, Emmanuel [7 ,9 ]
Capellier, Gilles [8 ,9 ,10 ]
Westeel, Virginie [1 ,2 ,3 ]
机构
[1] Univ Hosp Besancon, Resp Med Dept, Besancon, France
[2] Univ Hosp, Methodol & Qual Life Oncol Unit, Besancon, France
[3] Univ Franche Comte, UMR 1098, Besancon, France
[4] Univ Hosp Besancon, Dept Geriatr, Besancon, France
[5] Univ Hosp Besancon, Dept Infect Dis, Besancon, France
[6] Univ Hosp Besancon, Dept Radiol, Besancon, France
[7] Univ Hosp Besancon, Anesthesia & Intens Care Unit, Besancon, France
[8] Univ Hosp Besancon, Med Intens Care Unit, Besancon, France
[9] Univ Franche Comte, Res Unit EA3920, Besancon, France
[10] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Clayton, Australia
来源
NATURE AND SCIENCE OF SLEEP | 2022年 / 14卷
关键词
SARS-CoV-2; pneumonia; obstructive sleep apnea syndrome; intensive care unit; POTENTIAL ROLE; LUNG-VOLUME; WEIGHT-GAIN; QUESTIONNAIRE; INFECTION; DISORDERS; OBESITY; RISK; STOP;
D O I
10.2147/NSS.S377946
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Sleep apnea (SA) was reported as possibly exacerbating symptoms of COVID-19, a disease induced by SARS-CoV-2 virus. The same comorbidities are common with both pathologies. This study aimed to estimate the prevalence, characteristics of SA and variation in AHI three months after severe COVID-19 requiring intensive care unit (ICU) admission.Methods: A prospective cohort of patients admitted to ICU for severe COVID-19 underwent an overnight home polygraphy 3 months after onset of symptoms, as part of a comprehensive follow-up program (pulmonary function tests, 6-minute walk tests and chest CT -scan). Patients with an apnea hypopnea index (AHI) >5 were considered as having SA. We performed a comparative descriptive analysis of 2 subgroups according to the existence, severity of SA and indication for effective SA treatment: patients with absent or mild SA (AHI <15) vs patients with moderate to severe SA (AHI >15).Results: Among 68 patients included, 62 (91%) had known comorbidities (34 hypertension, 21 obesity, 20 dyslipidemia, 16 type 2 diabetes). It has been observed a preexisting SA for 13 patients (19.1%). At 3 months, 62 patients (91%) had SA with 85.5% of obstructive events. Twenty-four patients had no or a mild SA (AHI <15) and 44 had moderate to severe SA (AHI >15). Ischemic heart disease exclusively affected the moderate to severe SA group. Except for thoracic CT-scan which revealed less honeycomb lesions, COVID-19 symptoms were more severe in the group with moderate to severe SA, requiring a longer curarization, more prone position sessions and more frequent tracheotomy.Conclusion: SA involved 91% of patients in our population at 3 months of severe COVID-19 and was mainly obstructive type. Although SA might be a risk factor as well as consequences of ICU care in severe COVID-19 infection, our results underline the importance of sleep explorations after an ICU stay for this disease.
引用
收藏
页码:2213 / 2225
页数:13
相关论文
共 51 条